You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Sale Disclosure
Seely Lynn · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$7.34K
Seely Lynn President And CEO
LYEL
Lyell Immunopharma
LYEL
Transaction date
May 11, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 35 days later
LYEL daily price context
Close on/before transaction
$19.2
May 11, 2026
First close after public filing
$12.44
Jun 16, 2026
30-day return after filing
+14.63%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 388 shares @ $18.91
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001327111-26-000003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$7.34K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Sale | May 11, 2026 | $7.34K |